Tag Archives: Pankaj Patel

Zydus Cadila gets US FDA nod to market drug for treatment of epilepsy

AHMEDABAD | MUMBAI | RAJKOT – In a press release submitted to the Indian Bourses on Tuesday, Cadila Healthcare Ltd (Dr Pankaj Patel owned Zydus Cadila group) said of having availed regulatory approval from US Food and Drugs Administration (USFDA) to market drug to treat epilepsy. Zydus Cadila has received the final approval from the

Zydus Cadila gets US FDA nod to market anti-arthritis drug

AHMEDABAD | MUMBAI | RAJKOT – In a regulatory filing submitted to the Indian Bourses on Thursday, Ahmedabad headquartered and Dr Pankaj Patel led Cadila Healthcare Ltd (Zydus Cadila Group) said of having received regulatory approvals from US FDA (Food & Drugs Department) to market anti-arthritis drug. Zydus Cadila has received the tentative approval from

Zydus Cadila to pay 1.56 billion rupees to acquires 51% stake in Windlass Healthcare

AHMEDABAD | MUMBAI | RAJKOT – Zydus Cadila Group will pay 1.55 billion (~155.55 crore) rupees to acquire 51% stake in Dehradun (Uttarakhand) headquartered Windlas Healthcare Pvt Ltd, the company press release submitted to the Exchanges in India on Monday read. The acquisition detailing regulatory document submitted to the exchange termed the objective of the

Cadila Healthcare (Zydus) gets USFDA nod for anti-fungal drug – Metronidazole tablets

AHMEDABAD | MUMBAI | RAJKOT – Cadila Healthcare Ltd (Dr Pankaj Patel led Zydus Cadila Group) has got United State Food and Drugs Administration (USFDA) final approval for Metronidazole tablets, used for treatment of infections caused by bacteria or parasites, the company press release said. Metronidazole tablets approval from USFDA is for dosage of 250

Zydus Wellness appoints Kulin Lalbhai (Arvind Group) as Additional Independent Director

AHMEDABAD | MUMBAI | RAJKOT – Zydus Wellness Ltd board appointed Kulin Lalbhai (Arvind Ltd – Sanjay Lalbhai family) as Additional Independent Director, for period of five consecutive years, subject to of the members at ensuing Annual General Meeting, the company said in statement to bourses in India. The board has approved to pay 50,000